Search

everythinglearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Nailfold dermoscopy is a simple, cheap way to check blood vessel changes in COVID-19 patients.

COVID-19 can cause skin issues like "COVID toes," rashes, hair loss, and hand eczema, and dermatologists are important for recognizing these signs.

Follicle Stimulating Hormone is important for fertility.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

RANKL causes lymph nodes to grow by making certain cells multiply.

G-1 promotes hair growth in female mice by activating specific signaling pathways.

Certain alkaloids could help create new coronavirus drugs.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Dermatologists should watch for skin symptoms in COVID-19 patients, prioritize urgent cases, and use telemedicine.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

Cholesterol affects coronavirus spread and could be a target for treatment.

Targeting endolysosomes may help treat COVID-19.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Managing myasthenia gravis is crucial and does not worsen primary Sjögren's syndrome.

Certain KIR genes in Indian SLE patients are linked to disease severity and could be biomarkers.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

Clinical trials should use innovative designs and biomarkers to improve precision therapy and patient outcomes.

CRH promotes fat production in skin cells, affecting conditions like acne.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Polysaccharides boost immunity and could help prevent and treat diseases.

Some gonadal hormone drugs can block filovirus entry into cells.

The COVID-19 pandemic increased the use of teledermatology to treat skin conditions in low-income areas, despite challenges like poor photo quality.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.